Laparoscopic radical 'no-touch' left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results by Abu Hilal, M. et al.
Laparoscopic radical ‘no-touch’ left pancreatosplenectomy
for pancreatic ductal adenocarcinoma: technique and results
M. Abu Hilal1 • J. R. C. Richardson1 • T. de Rooij2 • E. Dimovska1 • H. Al-Saati1 •
M. G. Besselink1,2
Received: 6 August 2015 / Accepted: 14 November 2015 / Published online: 16 December 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Background Laparoscopic left pancreatectomy has been
well described for benign pancreatic lesions, but its role in
pancreatic adenocarcinoma remains open to debate. We
report our results adopting a laparoscopic technique that
obeys established oncologic principles of open distal
pancreatosplenectomy.
Methods This is a post hoc analysis of a prospectively
kept database of 135 consecutive patients undergoing
laparoscopic left pancreatectomy, performed across two
sites in the UK and the Netherlands (07/2007–07/2015
Southampton and 10/2013–07/2015 Amsterdam). Primary
outcomes were resection margin and lymph node retrieval.
Secondary endpoints were other perioperative outcomes,
including post-operative pancreatic fistula. Definition of
radical resection was distance tumour to resection margin
[1 mm. All patients underwent ‘laparoscopic radical left
pancreatosplenectomy’ (LRLP) which involves ‘hanging’
the pancreas including Gerota’s fascia, followed by
clockwise dissection, including formal lymphadenectomy.
Results LRLP for pancreatic adenocarcinoma was per-
formed in 25 patients. Seven of the 25 patients (28 %) had
extended resections, including the adrenal gland (n = 3),
duodenojejunal flexure (n = 2) or transverse mesocolon
(n = 3). Mean age was 68 years (54–81). Conversion rate
was 0 %, mean operative time 240 min and mean blood
loss 340 ml. Median intensive/high care and hospital stay
were 1 and 5 days, respectively. Clavien–Dindo score 3?
complication rate was 12 % and ISGPF grade B/C pan-
creatic fistula rate 28 %; 90-day (or in-hospital) mortality
was 0 %. The pancreatic resection margin was clear in all
patients, and the posterior margin was involved (\1 mm)
in 6 patients, meaning an overall R0 resection rate of 76 %.
No resection margin was microscopically involved. Med-
ian nodal sample was 15 nodes (3–26). With an average
follow-up of 17.2 months, 1-year survival was 88 %.
Conclusions A standardised laparoscopic approach to
pancreatic adenocarcinoma in the left pancreas can be
adopted safely. Our study shows that these results can be
reproduced across multiple sites using the same technique.
Keywords Pancreas  Laparoscopy  Surgery  Distal
pancreatectomy  Malignancy  Cancer
Abbreviations
LDP Laparoscopic distal pancreatectomy
LRLP Laparoscopic radical ‘no-touch’ left
pancreatosplenectomy
UHS University Hospital Southampton, Southampton
AMC Academic Medical Center, Amsterdam
ISGPF International Study Group Definition on
Pancreatic Fistula
CT Computed topography
MDT Multidisciplinary team
MRI Magnetic resonance imaging
M. Abu Hilal and J. R. Richardson have contributed equally to the
scientific content of this paper.
& M. Abu Hilal
Mohammed.AbuHilal@uhs.nhs.uk; abuhilal9@gmail.com
1 University Hospital Southampton NHS Foundation Trust, E
Level, Tremona Road, Southampton SO16 6YD, UK
2 Academic Medical Center, Amsterdam, The Netherlands
123
Surg Endosc (2016) 30:3830–3838
DOI 10.1007/s00464-015-4685-9
and Other Interventional Techniques 
Laparoscopic distal pancreatectomy (LDP) has been shown
to be feasible, safe and cost-effective in the management of
benign lesions in the body and tail of the pancreas [1–3].
Several meta-analyses have shown excellent results for
LDP, at least comparable to those obtained in open surgery
[4–9]. However, the validity of the laparoscopic approach
when it comes to the management of pancreatic ductal
adenocarcinoma is still unclear [10].
Traditional surgical teachings have emphasised metic-
ulous surgical dissection with formal lymphadenectomy
and the adoption of ‘no-touch’ techniques in order to obtain
a radical oncological resection with minimal risk of tumour
dissemination and seeding. These principles have been
translated to open distal pancreatectomy for ductal ade-
nocarcinoma by Strasberg et al. [11]. Many would doubt
that these high oncological standards can be achieved
laparoscopically, and hence, the oncological efficiency of
the laparoscopic approach for malignant lesions in the
pancreas is still open to debate.
In the absence of a randomised study, data are limited to
prospective cohort studies. One series compared results of
open and laparoscopic distal pancreatosplenectomy in
patients with adenocarcinoma from 9 academic centres
over an 8-year period [12]. In that paper, the authors
reported on 23 of 212 patients (11 %) who underwent LDP
for adenocarcinoma, of which 4 were converted to an open
procedure and 4 were completed with a hand-assisted
approach. The 74 % R0 resection rate for LDP was not
inferior to the 66 % R0 resection rate for open distal
pancreatectomy. In this study, the LDP technique used for
adenocarcinoma was similar to the technique used for
benign disease. Two studies report on the subject of the
feasibility of the laparoscopic approach oncologically and
showed promising results with 13 case series [13] showing
an R1 resection rate of 23 % and a non-inferiority study
[14] showing equivalence versus the open approach. Five
further selected series [15–19] report on laparoscopic distal
pancreatectomy for a mixture of benign and malignant
conditions using multiple described techniques including
radical en bloc resection in one series preserving the
spleen. Between them a total of 56 patients underwent LDP
for pancreatic ductal adenocarcinoma. Conversion rates
ranged from 0 to 66 %, with surgical margin positivity as
low as 0 % and average nodal sample ranging from 6 to
19.8.
We herein report results in performing left pancre-
atosplenectomy (LRLP) for ductal adenocarcinoma of the
pancreas across two university hospitals. We also highlight
special tips and tricks that we adopt to ensure a safe and
oncologically efficient laparoscopic resection.
Methods
Patients
Data on 135 consecutive patients from two university
hospitals (105 University Hospital Southampton (UHS:
07/2007–07/2015), 30 Academic Medical Center Amster-
dam (AMC: 10/2013–07/2015) undergoing LDP were
prospectively collected in a digital database. These inclu-
ded patients undergoing LDP for benign disease and those
undergoing LRLP (see ‘Technique’ section) for pancreatic
adenocarcinoma. Prospective data collection included:
patient demographics, operative details, post-operative
details (including complications) and survival.
Procedures were performed by two surgeons over a
7-year period (July 2007 to May 2015) assisted by one or
two senior trainees or fellows; the technique was developed
at UHS and was also introduced in the AMC after a fel-
lowship at UHS.
All patents were imaged pre-operatively using computed
topography (CT) of the abdomen and pelvis. Where
malignancy was suspected, formal multidisciplinary team
(MDT) evaluation was undertaken (including CT, endo-
scopic ultrasound and magnetic resonance imaging (MRI)
if needed). Biopsy was not performed for solid lesions to
avoid seeding of malignant cells. All patients with loca-
lised left-sided disease were treated laparoscopically, even
if this required adrenalectomy or small bowel resec-
tion. Patients were not considered for laparoscopic surgery
if the MDT consensus was that the patient required an
extended multivisceral resection, requiring colonic, renal
or gastric resections or mesenteric vein resection which
could not be performed laparoscopically underwent open
surgery.
When indicated patients were assessed intra-operatively
with laparoscopic ultrasound (see ‘Technique’ section).
Only patients undergoing LRLP for adenocarcinoma of
the pancreas, confirmed on post-operative histopathology,
were included in the study and therefore used in the
analysis.
Definitions
Complications were classified using the Clavien–Dindo
score [20]; minor complications were considered grade I–
II, and major complications were considered to be anything
scored III or greater. Only clinically relevant (grade B/C)
ISGPF grade post-operative pancreatic fistula were regis-
tered [21].
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Margin status was determined at histopathological
examination of the resected specimens in all cases.
Specifically by assessing the tumours proximity to all
surfaces of the gland, including anterior, posterior and
staple line where an R0 resection represented tumour
[1 mm from the resection margin or pancreatic surface,
R1 resection represented tumour B1 mm from the resec-
tion margin or pancreatic surface (not as in previous
studies: microscopically negatively involved resection
margin) and R2 resection represented a macroscopically
positive margin [22]. All specimens were further examined
to determine both lymph node yield and positivity to pro-
vide an accurate staging of the resected tumour using the
TNM American Joint Committee on Cancer (AJCC) 7th
edition [23].
LRLP operative technique
Patients are positioned supine with a wedge under their left
side to achieve a 30 tilt. In our experience, a tilt of more
than 30 can make the access to the neck of the pancreas
and the coeliac trunk more difficult. After open sub/supra-
umbilical cut-down, a 12-mm trocar is inserted and pneu-
moperitoneum established. Further 3 trocars are inserted
under vision; one 5 mm high in the epigastrium, a 5 mm at
the left anterior axillary line, 3–5 cm under the costal
margin, and a 12-mm port between the umbilical and left
flank port (Fig. 1). Trocar position should be adapted to
both the size of the patient and the location of the tumour
(body or tail).
Dissection is performed using a combination of dia-
thermy hook, ultrasonic dissector (Harmonic ACE, Ethicon
EndoSurgery, Cincinnati, OH, USA, or Lotus Laparoscopic
Dissecting Shears, SRA Developments Ltd, Devon, UK),
5 mm or 10 mm clip applicators (Ligamax/Ligaclip, Ethi-
con EndoSurgery) and, for vessels larger than 7 mm, an
endoscopic ligation system (Hem-o-lok, Teleflex, NC,
USA).
A Nylon tape 3 9 70 mm (Ethicon Nylon Tape Ethicon
EndoSurgery), one red and one blue sling 2 9 70 mm
(Silicone Sling, DTR Medical, Swansea, UK) are each
divided in four and used for the hanging and slinging
manoeuvres during the procedure (red slings for arteries,
blue slings for veins and the nylon tape for the pancreas).
We prefer short lengths as this is enough for the purpose,
preventing multiple slings and tapes disturbing the opera-
tive field, and allows easier passage through a 5-mm port.
Step 1: Access and exposure
Following diagnostic laparoscopy, the gastrocolic ligament
and short gastrics are divided and a monofilament non-
absorbable suture is passed twice through the posterior
gastric wall. This suture is externalised via the fascial
opening used for the epigastric port, thus retracting the
stomach and exposing the pancreas and the lesser sac. The
spleno-colic ligament is divided, and the splenic flexure
mobilised to permit a complete exposure of the pancreatic
tail. Laparoscopic ultrasound is performed if needed to
determine tumour location or extension. If the splenic
artery is visible, it is dissected, slung and occluded using a
laparoscopic bulldog applicator until a definitive division
of the splenic artery is achieved. This manoeuvre reduces
pancreatic and splenic vascularisation and therefore blood
loss during the dissection.
Step 2: Gerota’s dissection and pancreatic hanging
The inferior border of the pancreas is dissected in an area
distant from the neoplasm (normally distal unless the lesion
is in the tail). The mobilisation continues down until
Gerota’s fascia (or: renal fascia) is identified, which is then
incised and lifted (Fig. 2). The posterior plane is developed
from here between this and the adrenal gland towards the
superior pancreatic margin. The superior margin is then
dissected and Gerota’s fascia is incised at the same level,
thus joining the dissection from below. A soft grasper is
passed through this developed plane inferiorly until the tip
is seen from the superior margin and a nylon tape is then
pulled through and secured with an endoscopic clip (Hem-
o-lok, Teleflex, NC, USA), thus allowing the pancreas to
be ‘hung’ (Fig. 3). The dissection of the inferior margin
and the development of the posterior plane are continuedFig. 1 Port placement
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clockwise towards the splenic/superior mesenteric vein
junction. A second tape is passed under the pancreas to the
right of the neoplasms to help in lifting the pancreatic
body, offering adequate tissue tension and creating a clear
dissection plane from the retroperitoneum.
Step 3: Vessels
The tunnel under the pancreatic neck plane is then devel-
oped using a combination of blunt dissection and, if nee-
ded, hydrodissection with a regular laparoscopic suction
device. In some cases, the hepatic artery is dissected and
slung to permit the passage of a third nylon tape around the
neck of the pancreas. Lifting the pancreas with the two
medial tapes offers an excellent view of the pancreas and
the posterior vascular structures. The splenic vein is dis-
sected, slung (Fig. 4) and secured with two endoscopic
clips (Hem-o-lok, Teleflex) at its junction with the superior
mesenteric vein, then divided. Depending on the relation to
the tumour, the inferior mesenteric vein is transected or left
intact.
Step 4: Pancreatic transection
The second part of the dissection is in a medial–lateral
direction. The pancreas is transected at the neck keeping a
clear margin from the lesion, using a linear stapler device
(Echelon 60, Ethicon EndoSurgery) with a vascular car-
tridge employing a slow compression technique allowing
approximately 120 s for complete closure of the stapler
with an aim to prevent rupture of the pancreatic capsule.
Step 5: Lymphadenectomy
The pancreas is then dissected from the hepatic artery and
the coeliac trunk performing a full nodal clearance
including station 8, hepatic nodes (Fig. 5). The origin of
the three coeliac vessels is seen, and nodal clearance is
performed down to the coeliac trunk and inferiorly on the
left border of the aorta to the left of the superior mesenteric
artery; the splenic artery is slung (if not done before) and
secured with three endoscopic clips (Hem-o-lok, Teleflex)
and divided at its origin. If needed the left gastric artery is
slung and lifted to help in completing the nodal clearance
around it. The clockwise dissection is continued towards
the spleen, taking any remnant attached tissue and nodes
including the Gerota’s fascia.
Fig. 2 Mobilising Gerota’s fascia caudo-cranial direction
Fig. 3 Slinging of pancreas with nylon tape
Fig. 4 Slinging of splenic artery and vein
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Step 6: Extraction, closure
The spleen is then released from its remaining retroperi-
toneal attachments. The specimen is removed from a
Pfannenstiel incision (approximately 6 cm) in an imper-
meable extraction bag (Endocatch, Ethicon EndoSurgery)
that was passed through a 15-mm port. Care is taken not to
crush the specimen in order to compromise pathological
assessment. The peritoneum is closed with one vicryl and
the fascia with a one PDS loop, and this is then visualised
laparoscopically to ensure optimal closure. The resection
site is inspected and haemostasis ensured. The stump is
only secured with interrupted PDS 3/0 sutures if there are
areas of parenchymal fractures or ongoing bleeding. A
combination of absorbable haemostatic material (SURGI-
CEL SNoW, Ethicon Endosurgery) and haemostatic glue
(EVICEL Fibrin Sealant (Human), Ethicon Endosurgery)
can be applied. A 20F Wallace drain is placed adjacent to
the resection line of the pancreas with a loop in the splenic
bed with 2–3 additional side holes at this site and secured.
The fascial defects on all ports larger than 5 mm are closed
using an absorbable multifilament suture and skin closed
using absorbable monofilament.
Results
Patient demographics and operative details
Of the 135 patients undergoing LDP during the study
period, 25 patients (18.5 %) underwent LRLP for adeno-
carcinoma of the pancreas (20 at UHS and 5 at AMC). Of
these, 24 patients were suspected as adenocarcinoma pre-
operatively and underwent planned LRLP following
laparoscopic assessment and in 1 patient a radical resection
was performed based on intra-operative findings (this
patient had background chronic pancreatitis and an uncer-
tain diagnosis pre-operatively). Seven of the 25 patients
had extended resections, and these involved subtotal left
adrenal gland resection (n = 3), duodenojejunal flexure
wedge resection (using an endoscopic stapling device)
(n = 2) and partial resection of the transverse mesocolon
(not involving the colon itself) (n = 3).
Mean age was 68 years, and 48 % of patients were
male. All cases were completed via a pure laparoscopic
technique (i.e. no use of hand ports) with a 0 % conversion
rate. Mean operative time was 240 min (range
120–390 min). Average blood loss was 340 ml (range
50–1000 ml), and none of the patients required intra-op-
erative or post-operative blood transfusion. These findings
are summarised in Table 1. During the study period, 5
patients underwent open resections 3 at UHS (all due to
scheduling difficulties and surgeon non-availability at the
time) and 2 at AMC (1 due to tumour involving the celiac
axis requiring reconstruction and 1 had an exploratory open
procedure to establish respectability in which they
proceeded).
Post-operative details
Median hospital stay was 5 days (range 2–57 days).
Patients stayed a median of 1 day in intensive care or high
dependency unit (range 0–27 days). Median ward stay was
3 days (range 1–30 days). An enhanced recovery pro-
gramme was introduced during the series which brought
hospital stay down to as low as 2 days [24]. Five patients
were readmitted within 30 days (1 with nausea and vom-
iting, 2 with peripancreatic collections and 2 to manage
post-operative pancreatic fistulae). Two patients (8 %)
required radiological drainage for infected peripancreatic
collections, and 11 patients developed ISGPF post-opera-
tive pancreatic fistulae (44 %; of any grade) with seven of
these patients (28 %) developing a ISGPF grade B fistula
meaning that they were discharged with the surgical drain
in situ. This was managed by serially withdrawing the
surgical drain at outpatient visits. The 90-day mortality was
0 %. The average follow-up was 17.2 months in that time
Fig. 5 Lymphadenectomy common hepatic artery
Table 1 Patient demographics and intra-operative results
Demographic n = 25
Age (years) 68 (54–81)
Male (%) 48 %
Conversion rate (%) 0 %
Operating time (min) 240 (120–390)
Blood loss (mL) 340 (50–1000)
Intra- or post-operative blood transfusion (units) 0
3834 Surg Endosc (2016) 30:3830–3838
123
there were 6 mortalities at 2 at 6 months, 1 at 11 months, 1
at 12 months, 1 at 15 months and 1 at 43 months post-
operatively, leading to an overall survival of 76 % and a
1-year survival of 88 %. These findings are summarised in
Table 2.
Histopathology details
All patients were shown to have ductal adenocarcinoma of
the pancreas upon histopathological assessment of resected
specimens, and these findings are summarised in Table 3.
Of these, 2 patients (8 %) were found to have T4 disease
(both N1), 21 (84 %) found to have T3 disease, 1 (4 %)
found to have T2 and 1 (4 %) found to have T1 disease.
Eighteen patients (72 %) had N1 disease, and no patients
had N2 disease.
Average tumour size was 36 mm (range 15–82 mm)
with median nodal sample of 15 (range 3–26 nodes) of
which a median of 2 positive nodes were found (range 0–5
nodes). The staple margin was free of tumour in all
patients. Six patients (24 %) had positive posterior ‘mar-
gins’ as tumour was found less than 1 mm from the sur-
face, of these there was no microscopic involvement of
tumour in the staple margin or posterior margin, and these
patient characteristics are summarised in Table 4. Ten
patients demonstrated perineural invasion, and ten patients
had signs of vascular invasion with one of these demon-
strating tumour thrombus in the splenic vein. Upon
microscopic examination of the specimens of extended
resections [adrenal gland (n = 3), duodenojejunal flexure
(n = 2), mesocolon (n = 3)], margins were found to be
adequately clear.
Discussion
This study described the results of laparoscopic left pan-
creatosplenectomy exclusively for pancreatic ductal ade-
nocarcinoma in two university hospitals in the UK and the
Netherlands. Based on the results in 25 patients, we con-
cluded that, in selected patients, the standardised LRLP
approach to pancreatic adenocarcinoma in the left pancreas
can be adopted and reproduced with results equivalent to
those obtained in historical open series.
Previous studies have grouped results of LDP for
malignant and benign conditions [4–9], hampering specific
analyses of the laparoscopic management of pancreatic
ductal adenocarcinoma. Of the studies that report specifi-
cally on LDP for pancreatic cancer, Lee et al. [18] did so in
a highly selected group of patients (tumours confined to the
pancreas), and whilst reporting excellent results their out-
comes are not applicable to the treatment of all patients
with left-sided cancers. Kawaguchi et al. [19] also showed
promising results though their technique departs widely
from established oncosurgical practice since they preserved
the spleen in 17 of 24 patients [11].
A recent report from the National Cancer Database in
the USA [25] included patients from 1500 hospitals
between 2010 and 2011. This retrospective study reported
on 144 patients undergoing laparoscopic distal pancreate-
ctomy for ductal adenocarcinoma, and of these, there was
12 % margin positivity with a median nodal sample of 13.
They compared these outcomes with patients undergoing
open distal pancreatectomy during the same time period
and found equivocal oncological outcome measures.
Oncological surgery requires a radical resection, ade-
quate lymphadenectomy and meticulous ‘no-touch’ dis-
section as it may prevent seeding and tumour cell
dissemination [26, 27]. The oncological approach to
tumours of the body and tail of the pancreas has been well
described in open surgery [11, 28–31]. This involves the
division of the pancreas at the neck, removing the pan-
creatic body and tail, including Gerota’s fascia (as stressed
by Strasberg [11]) using a medial-to-lateral approach. The
resection may include the adrenal gland in case of tumour
Table 2 Post-operative results
Days on ITU/HDU (days) 1 (0–27)
Ward stay (days) 3 (1–30)
Total hospital stay (days) 5 (2–57)
Clavien–Dindo C3 complication rate (%) 12
Radiological post-operative intervention (%) 8
ISGPF grade B/C fistula rate (%) 28
Readmission rate (%) 20
90-day mortality (%) 0
Follow-up (months) 17.2 (±16.5)
ICU intensive care unit, HDU high dependency unit
Table 3 Histopathology
T1 1 (4 %)
T2 1 (4 %)
T3 21 (84 %)
T4 2 (8 %)
N0 7 (28 %)
N1 18 (72 %)
N2 0 (0 %)
Tumour size (mm) 36 (15–82)
Total nodes (range) 15 (3–26)
Positive nodes 2 (0–5)
Specimen length (mm) 100 (70–160)
Retroperitoneal margin positive 24 %
Multivisceral resection 6 (24 %)
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extension. Strasberg described the oncological lym-
phadenectomy based on the reviewed concepts of lym-
phatic drainage of the pancreas described by O’Morchoe
[32]. The oncological approach to these tumours is reported
by Ferna´ndez-Cruz et al. [13] who describe a laparoscopic
variant of Strasberg’s radical antegrade modular pancre-
atosplenectomy on 13 patients with pancreatic adenocar-
cinoma, and they showed an R1 resection rate of 23 % in
this group with an average nodal sample of 14.5. A study
from Pittsburg, USA [14], involving 28 patients undergo-
ing LDP and 34 having open surgery both for adenocar-
cinoma over an 8-year period showed non-inferiority of the
laparoscopic approach in their analysis specific to onco-
logical outcome measures.
In LDP for benign disease, the pancreas is usually
divided just proximally to the lesion. Routine division at
the pancreatic neck is not mandatory and not the best
option to preserve parenchyma. This is different in onco-
logical resection for cancer, where the whole left pancreas
should be removed in order to obtain a radical resection
clearing all the lymphatic stations and Gerota’s fascia. This
is why we elect to call our resection left pancreatectomy
differentiating it from the distal pancreatectomy.
Our described technique for LRLP takes into consider-
ation all the above. Hanging the pancreas at different levels
allows for ‘no-touch’ dissection, keeping the planes under
tension, whilst offering excellent retropancreatic views.
Slinging the vessels permits a better understanding of the
anatomy before dividing any vital structures but also
facilitates nodal clearance around and between the vessels.
Only a few series have clearly reported on margins and
nodal clearance after open distal pancreatectomy for pan-
creatic ductal adenocarcinoma. The previously mentioned
multicentre study [12] comparing laparoscopic and open
distal pancreatectomies for adenocarcinoma in 39 patients
reported no difference in R1 resection rate between
laparoscopic (26 %) and open (34 %). R1 was defined as a
microscopically involved margin and not as a\1-mm free
margin. A single-centre study [15] including 18 patients
undergoing LDP for ductal adenocarcinoma reported a 3 %
R1 resection rate. In this study, R1 was defined as a
microscopically involved resection margin. Our results
compare favourably to these studies; if we were to use the
same (old) definition, the current series has a 4 % R1
resection rate. However, we believe that R1 resection
should be defined as \1 mm from the transection or the
posterior margin as recommended by Verbeke et al. [21].
Even when we apply this definition, our R1 rate is com-
parable to previously reported outcomes in open surgery.
The factors contributing to causing a positive margin are
beyond the scope of this study, but in analysing our patients
it can be observed that all are T3 and T4 disease and lie on
the posterior surface of the pancreas.
A recent analysis by Baker et al. [33] concluded that
LPD failed to provide a lymphadenectomy comparable to
open distal pancreatectomy as only five lymph nodes were
retrieved with the laparoscopic approach versus nine with
the open approach. The previously mentioned multicentre
analysis by Kooby et al. [12] reported on a mean nodal
sample of 13.8 nodes. Our histopathological results (me-
dian nodal sample 15, range 3–26 nodes, mean tumour size
3.6 cm) are comparable with series on open distal pan-
createctomy with median nodal sample 15 and tumour
range between 2 and 3.6 cm [12, 15–17]. Although the
advantage of a formal lymphadenectomy in distal pancre-
atectomy has not been proven, this cannot be an excuse for
suboptimal lymphadenectomy during a laparoscopic
approach to pancreatic ductal adenocarcinoma.
Our hospital stay of 5 days, mean blood loss of 340 ml
and operative time of 240 min also compare favourably to
large open series, such as reported from Johns Hopkins
[30] with average hospital stay of 9 days, mean blood loss
of 912 ml and operative time of 300 min in 235 open distal
pancreatectomies including 43 for pancreatic ductal
adenocarcinoma.
Our study reports a 0 % conversion rate with a pure
laparoscopic technique, despite the extensive surgery
required in some cases. This was due to tumour size and
invasion of adjacent organs such as the adrenal gland, the
mesocolon and duodenal jejunal flexure which required
Table 4 Retroperitoneal margin positive tumour characteristics
Survival
(months)
Size
(mm)
pTN Nodal
involvement
Retroperitoneal margin
(mm)
Perineural
invasion
Vascular
invasion
Infiltration of adjacent
organs
6 (Dead) 15 T3N0 0 of 3 0.5 Yes No No
12 (Dead) 50 T3N0 3 of 21 \1 Yes No No
28 (Dead) 30 T4N1 2 of 14 \1 No Yes Yes
6 (Dead) 45 T3N1 3 of 26 \1 No Yes Yes
5 (Alive) 25 T3N1 1 of 10 0.7 No No No
11 (Dead) 29 T3N1 3 of 20 \1 Yes Yes No
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resection in 2 cases. In the five previously mentioned
studies on LDP in adenocarcinoma, the mean conversion
rate across all studies was 22 % (range 0–66 %). A large
series from the Memorial Sloan Kettering Cancer Center
reported on 343 distal pancreatectomies over a 7-year
period. Only 18 patients underwent a LDP for a malig-
nancy. The conversion rate in all 107 laparoscopic proce-
dures was 30 % [17]. No data on radicality in the
laparoscopic procedures for malignancy were provided.
The current study is primarily limited by its small
numbers. However, 25 cases completed fully laparoscopi-
cally compares favourably with 15 procedures completed
laparoscopically in a multicentre study including nine
centres [12]. Retrospective studies carry a risk of selection
bias. Notably, our study has included all comers regardless
of size and location of the tumour. In addition, we have
included tumours which needed multivisceral resections to
achieve a radical clearance, minimising potential selection
bias. In addition, all cases were performed by one of the
two laparoscopic pancreatic surgeons using the same
standardised approach.
Last but not least, in addition to safety, feasibility and
oncological efficiency, a surgical technique must be
reproducible, easy to teach and easy to ensure validity and
expansion. Our report represents an excellent example of
how after a year of fellowship and mentoring (at UHS), one
of our surgeons was able to safely establish LRLP in his
centre, adopting the same technique and achieving similar
results. We believe our described technique can be useful
for surgeons who are starting the laparoscopic approach in
their centres as most of the technical items explained can
be useful in LDP for benign disease as well.
Our study suggests that where sufficient expertise with
laparoscopic resections for benign pancreatic conditions is
available [2], LRLP can be used as a treatment for pan-
creatic lesions regardless of aetiology. Where malignancy
is suspected, a ‘no-touch’ technique following principles
used for radical open surgery should be adopted, and this
can be done so using our approach described across mul-
tiple sites. This technique can be used in robotic resections
in future practice, as it is based on established oncological
principles which remain relevant regardless of surgical
approach. Further work should focus on long-term onco-
logical outcome of this procedure and larger multicentre
studies focusing solely on LRLP for pancreatic ducal
adenocarcinoma. This indication could represent an ideal
proposal for a randomised controlled multicentre trial.
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